Whole-body MRI for Detecting Bone Marrow Metastases

被引：5

作者：

Kwee, Thomas C. ^{[1
]}

Takahara, Taro ^{[1
]}

Katahira, Kazuhiro ^{[2
]}

Nakanishi, Katsuyuki ^{[3
]}

机构：

[1] Univ Med Ctr Utrecht, Dept Radiol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands

[2] Kumamoto City Hosp, Dept Radiol, Kumamoto, Kumamoto 8620965, Japan

[3] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiol, Higashinari Ku, Osaka 5378511, Japan

来源：

PET CLINICS | 2010年 / 5卷 / 03期

关键词：

Whole-body; Magnetic resonance imaging; MRI; Bone marrow; Metastases;

D O I：

10.1016/j.cpet.2010.03.006

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

The bone marrow is a common site for metastasis in cancer. Accurate detection of bone marrow metastases is of major importance because of its therapeutic and prognostic implications. MRI allows direct visualization of all bone marrow components at a good spatial resolution. Furthermore, thanks to technologic advances, it is now possible to perform MRI of the entire body. For these reasons, it is a potentially valuable technique for the detection of bone marrow metastases. This article reviews whole-body MRI techniques and the diagnostic performance of whole-body MRI compared with PET for the detection of bone marrow metastases. © 2010 Elsevier Inc. All rights reserved.

引用

页码：297 / 309

页数：13

共 50 条

[1]

Bain BJ, 2006, HAEMATOLOGICA, V91, P1293

[2] Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET [J].

Basu, Sandip ;

Torigian, Drew ;

Alavi, Abass .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (03) :465-471

[3]

Basu S, 2007, J CLIN ONCOL, V25, P1297, DOI 10.1200/JCO.2006.10.0123

[4] Clinical features of metastatic bone disease and risk of skeletal morbidity [J].

Coleman, Robert E. .

CLINICAL CANCER RESEARCH, 2006, 12 (20) :6243S-6249S

[5] Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow [J].

Daldrup-Link, HE ;

Rummeny, EJ ;

Ihssen, B ;

Kienast, J ;

Link, TM .

EUROPEAN RADIOLOGY, 2002, 12 (06) :1557-1566

[6]

Edelstyn G.A., 1967, CLIN RADIOL, V18, P158, DOI 10.1016/S0009-9260(67)80010-2

[7] Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer [J].

Eschmann, S. M. ;

Pfannenberg, A. C. ;

Rieger, A. ;

Aschoff, P. ;

Mueller, M. ;

Paulsen, F. ;

Anastasiadis, A. ;

Claussen, C. D. ;

Bares, R. ;

Schlemmer, H. P. .

NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2007, 46 (05) :161-168

[8]

Even-Sapir E, 2005, J NUCL MED, V46, P1356

[9] Whole-body MRI in comparison to skeletal scintigraphy for detection of skeletal metastases in patients with solid tumors [J].

Ghanem, N ;

Kelly, T ;

Altehoefer, C ;

Winterer, J ;

Schäfer, O ;

Bley, TA ;

Moser, E ;

Langer, M .

RADIOLOGE, 2004, 44 (09) :864-873

[10] Value of diffusion-weighted imaging for diagnosing vertebral metastases due to prostate cancer in comparison to other primary tumors [J].

Hackländer, T ;

Scharwächter, C ;

Golz, R ;

Mertens, H .

ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2006, 178 (04) :416-424

← 1 2 3 4 5 →